UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.
Computers have transformed our working lives. Now as they become pervasive elsewhere, leading experts call for an overhaul of research in human–computer interaction.